Effect of probiotic Saccharomyces boulardii on prevention of antibioticassociated diarrhea in adult outpatients with amoxicillin treatment;Efecto del probiótico Saccharomyces boulardii en la prevención de la diarrea asociada con antibióticos en adultos ambulatorios en tratamiento con amoxicilina

Revista Medica de Chile

Volumn 136, Issue 8, 2008, Pages 981-988

  Bravo, María Verónica ^a,b   Bunout, Daniel ^a   Leiva, Laura ^a   De La Maza, María Pía ^a   Barrera, Gladys ^a   De La Maza, Javier ^a   Hirsch, Sandra ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL DR SÓTERO DEL RÍO   (Chile)

Author keywords

Amoxicillin; Diarrhea; Saccharomyces

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; PLACEBO; PROBIOTIC AGENT;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; OUTPATIENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SACCHAROMYCES; YEAST;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; AMOXICILLIN; ANTI-BACTERIAL AGENTS; DIARRHEA; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PLACEBOS; PROBIOTICS; PROSPECTIVE STUDIES; SACCHAROMYCES; YEAST, DRIED; YOUNG ADULT;

EID: 54349088275     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. BARTLETT JG. Antibiotic-associated diarrhea. N Engl J Med 2002; 346: 334-40.
2. DE LA COCHETIERE MF, DURAND T, LEPAGE P, BOURREILLE A, GALMICHE JP, DORE J. Resilience of the Dominant Human Fecal Microbiota upon Short-Course Antibiotic Challenge. J Clin Microbiol 2005; 43: 5588-92.
3. LEVY J. The Effects of Antibiotic Use on Gastrointestinal Function. Am J Gastroenterol 2000; 95 (suppl): S8-S10.
4. BERGOGNE-BÉRÉZIN E. Treatment and Prevention of Antibiotic-Associated Diarrhea. Int J Antimicr Ag 2000; 16: 521-6.
5. YOUNG VB, SCHMIDT TM. Antibiotic-Associated Diarrhea Accompanied by Large-Scale Alterations in the Composition of the Fecal Microbiota. J Clin Microbiol 2004; 42: 1203-6.
6. CARON F, DUCROTTE P, LEREBOURS E, COLIN R, HUMBERT G, DENIS P. Effects of Amoxicillin-Clavulanate Combination on the Motility of the Small Intestine in Human Beings. Antimicrob Agents Chemother 1991; 35: 1085-8.
7. THOMAS MR, LITIN SC, OSMOND DR, CORR AP, WEAVER AL, LOHSE CM. Lack of Effect of Lactobacillus GG on Antibiotic-Associated Diarrhea: A randomized, Placebo-Controlled Trial. Mayo Clin Proc 2001; 76: 883-9.
8. ARMUZZI A, CREMONINI F, BARTOLOZZI F, CANDUCCI F, CANDELLI M, OJETTI V ET AL. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001; 15: 163-9.
9. MCFARLAND LV, SURAWICZ C, GREENBERG RN, FEKETTY R, ELMER GW, MOYER KA ET AL. Randomized Placebo-Controlled Trial of Saccharomyces boulardii in Combination with Standard Antibiotics for Clostridium difficile Disease. JAMA 1994; 271: 1913-8.
10. MCFARLAND LV, SURAWICZ C, GREENBERG RN, ELMER GW, MOYER KA, MELCHER SA ET AL. Prevention of β-Lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol 1995; 90: 439-48.
11. HÖGENAUER C, HAMMER HF, KREJS G, RETSINGER EC. Mechanisms and Management of Antibiotic-Associated Diarrhea. Clin Infect Dis 1998; 27: 702-10.
12. BEAUGERIE L, FLAHAULT A, BARBUR F, ATLANS P, LALANDE V, COUSIN P, M CADILHAC, & PETIT JC (FOR THE STUDY GROUP). Antibiotic-associated diarrhoea and Clostridium difficile in the community. Aliment Pharmacol Ther 2003; 17: 905-12.
13. WISTRÖM J, NORRBY SR, MYHRE EB, ERIKSSON S, GRANSTRÖM G, LAGERGREN L ET AL. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemoter 2001; 47: 43-50.
14. ALFA MJ, DU T, BEDA G. Survey of Incidence of Clostridium difficile Infection in Canadian Hospitals and Diagnostic Approaches. J Antimicrob Chemoter 1998; 36: 2076-80.
15. COLLINS MD, GIBSON GR. Probiotics, prebiotics, and synbiotics: appraches for modulating the microbial ecology of the gut. Am J Clin Nutr 1999; 69 (suppl): 1052S-7S.
16. BENGMARK S. Bioecologic Control of the Gastrointestinal Tract: The Role of Flora and Supplemented Probiotics and Synbiotics. Gastroenterol Clin N Am 2005; 34: 413-36.
17. DE ROOS NM, KATAN MB. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am J Clin Nutr 2000; 71: 405-11.
18. GILL HS, RUTHERFORD KJ, CROSS ML, GOPAL PK. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 2001; 74: 833-9.
19. SURAWICZ CM, ELMER GW, SPEELMAN P, MCFARLAND LV, CHINN J, VAN BELLE G. Prevention of Antibiotic-Associated Diarrhea by Saccharomyces boulardii: A prospective Study. Gastroenterology 1989; 96: 981-8.
20. LEWIS SJ, POTTS LF, BARRY RE. The Lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients. J Infect 1998; 36: 171-4.
21. KOTOWSKA M, ALBRECHT P, SZAJEWSKA H. Saccharomyces boulardii in the prevention of antibiotic-associated diarroea in children: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2005; 21: 583-90.
22. TOOTHAKER RD, ELMER GW. Prevention of Clindamycin-Induced Mortality in Hamsters by Saccharomyces boulardii. Antimicrob Agents Chemother 1984; 26: 552-6.
23. BUTS JP, BERNASCONI P. Saccharomyces boulardii: Basic Science and Clinical Applications in Gastroenterology. Gastroenterol Clin N Am 2005; 34: 515-32.
24. CASTAGLIUOLO I, RIEGLER MF, VALENICK L, THOMAS-LAMONT J, POTHOULAKIS CH. Saccharomyces boulardii Protease Inhibits the Effects of Clostridium difficile Toxins A and B in Human Colonic Mucosa. Infect Immun 1999; 67: 302-7.
25. DE SUTTER AI, DE MEYERE MJ, CHRITIAENS TC, VAN DRIEL ML, PEERSMAN W, DE MAESENEER JM. Does amoxicillin improve outcomes in patients with purulent rhinorrhea? A pramatic randomized double-blind controlled trial in family practice. J Fam Pract 2002; 51: 317-23.
26. SHER LD, MC ADOO MA, BETTIS RB, TURNER MA, LI NF, PIERCE PF. A Multicenter, Randomized, Investigator-Blinded Study of 5-10 day Gatifloxacin versus 10-day Amoxicillin/clavulanate in Patients with Acute Bacterial Sinusitis. Clin Ther 2002; 24: 269-81.
27. BUCKO AD, HUNT BJ, KIDD SL, HOM R. Randomized, Double-Blind, Multicenter Comparison of Oral Cefditoren 200 or 400 mg BID with either Cefuroxime 250 mg in Uncomplicated Skin and Skin-.Structure Infections. Clin Ther 2002; 24: 1134-47.
28. CAPERTON EM, HEIM-DUTHOY KL, MATZKE GR, PETERSON PK, JOHNSON RC. Ceftriaxone Therapy of Chronic Inflammatory Arthritis. A Double-Blind Placebo Controlled Trial. Arch Intern Med 1990; 150: 1677-82.
29. PETITPRETZ P, ARVIS P, MAREL M, MOITA J, URUETA J,THE CAP5 MOXIFLOXACIN STUDY GROUP. Oral Moxifloxacin vs High-Dosage Amoxicillin in the Treatment of Mild-to-Moderate, Community-Acquired, Suspected Pneumococcal Pneumonia in Adults. CHEST 2001; 119: 185-95.
30. ARGUEDAS A, EMPARANZA P, SCHWARTZ RH, SOLEY C, GUEVARA S, DE CAPRARIIS PJ ET AL. A randomized, multicenter, double blind, double dummy trial of single dose azithromycin versus high dose amoxicillin for treatment of uncomplicated acute otitis media. Pediatr Infect Dis J 2005; 24: 153-61.
31. D'SOUZA A, RAJKUMAR CH, COOKE J, BULPITT CJ. Probiotics in prevention of antibiotic associated diarrhoea: neta-analysis. BMJ 2002; 324: 1361-6.
32. CREMONINI F, DI CARO S, NISTA EC, BARTOLOZZI F, CAPELLI G, GASBARRINI G & GASBARRINI A. Meta-analysis: the effect of probiotic administration on antibiotic associated diarrhoea. Aliment Pharmacol Ther 2002; 16: 1461-7.
33. BOYLE RJ, ROBINS-BROWNE RM, TANG MLK. Probiotic use in clinical practice: what are the risks? Am J Clin Nutr 2006; 83: 1256-64.